Comparing the cost-effectiveness of linezolid to trimethoprim/sulfamethoxazole plus rifampicin for the treatment of MRSA infection: a health-care system perspective

Autor: von Dach, E., Morel, C.M., Murthy, A., Pagani, L., Macedo-Vinas, M., Olearo, F., Harbarth, S.
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Popis: To date few industry-independent studies were conducted to compare the relative costs and benefits of drugs to treat MRSA infection. We performed a stochastic cost-effectiveness analysis comparing two treatment strategies -- linezolid versus trimethoprim-sulfamethoxazole plus rifampicin -- for the treatment of MRSA infection.
Databáze: OpenAIRE